Canada’s Lorus shares jump on Australian patent

Canada’s Lorus shares jump on Australian patent
May 3 (Reuters) – Shares of Canada’s Lorus Therapeutics Inc soared as much as 24 percent after Australian regulators allowed a new patent for its clinical-stage leukemia drug.